DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Morolimumab
Morolimumab
Fig. L COMPOSITIONS and METHODS to INHIBIT STEM CELL and PROGENITOR CELL BINDING to LYMPHOID TISSUE and for REGENERATING GERMINAL CENTERS in LYMPHATIC TISSUES
WO 2012/144892 Al 26 October 2012 (26.10.2012) P O P C T
(12) United States Patent (10) Patent No.: US 9.498,544 B2 Ennis Et Al
Modifications to the Harmonized Tariff Schedule of the United States To
I Regulations
(INN) for Biological and Biotechnological Substances
INN Working Document 05.179 Update 2011
INN Working Document 05.179 Update December 2010
IUPAC Glossary of Terms Used in Immunotoxicology (IUPAC Recommendations 2012)*
(12) Patent Application Publication (10) Pub. No.: US 2016/0184445 A1 Perroth Et Al
International Nonproprietary Names (Inn) for Biological and Biotechnological Substances
(INN) for Biological and Biotechnological Substances
WO 2018/067987 Al 12 April 2018 (12.04.2018) W !P O PCT
(12) United States Patent (10) Patent No.: US 9,446,134 B2 Maggio (45) Date of Patent: *Sep
WO 2013/093809 Al 27 June 2013 (27.06.2013) P O P C T
WO 2014/093640 Al 19 June 2014 (19.06.2014) P O P C T
International Nonproprietary Names (INN) for Biological and Biotechnological Substances
Wo 2010/095940 A2
Top View
Customs Tariff - Schedule Xxi - 1
WO 2017/148880 Al 8 September 2017 (08.09.2017) P O P C T
14897/06 ADD 1 ME/Mpd 1 DG E II COUNCIL of the EUROPEAN
Esophagitis: Drugs Picture of Iron Pill Material in Biopsy TT’S Kodachrome 1St Page Folder Iron Medication Injury Medications/Drugs
Immunomodulatory Treatment for the Intractable Paediatric Epilepsies Luis E
(INN) for Biological and Biotechnological Substances
Thalidomide - Wikipedia, the Free Encyclopedia
Assessment of the Evolution of Cancer Treatment Therapies
International Nonproprietary Names (INN) for Biological and Biotechnological Substances
WO 2014/108198 Al 17 July 2014 (17.07.2014) P O P C T